Research & Development



  最終老鷹隊以105比91大勝猛龍,將戰績提升到5勝1負!   黎舟心髒跳的還有些快,松開他的手,他這幾天又斷斷續續的做夢,其他的記不清,但是黎江唇角的血他記得清楚。黎舟剛醒,聲音還有些沙啞道︰“有哪兒不舒服跟我說,要出門也記得告訴我一聲。”色   都這麼倒霉了,還能微笑面對。综合   听你瞎扯!   劉莽第一次和對手交換聯系方式,而且還是個超級巨星……他準備回去清算一下今天獲得的獎勵壓壓驚。嗯学姐好紧校园春色 第6章 意外

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo